Opthea is headquartered in Melbourne, Australia.
Opthea disclosed revenue of 25M AUD for 2020 and 37M AUD for 2019.
Opthea has 33 employees.
Opthea is a life science company.
Opthea was founded in 1984.
Level 9 505 Little Collins Street,
Melbourne,
VIC 3000
Australia,
61 3 9826 0399
www.opthea.com
Opthea is a biotechnology company developing novel biologic therapies for the treatment of eye diseases. Opthea's lead compound, OPT-302, blocks two members of the vascular endothelial growth factor family, namely VEGF-C and VEGF-D, which cause blood vessels to grow and leak. Aberrant blood vessel growth and vascular leakage are hallmarks of several eye diseases including wet age-related macular degeneration (wet AMD). Opthea was formed in 1984 and is based in Melbourne, Australia.
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
